Guillain-Barré syndrome and influenza vaccines: A meta-analysis. CA Martín Arias LH, Sanz R, Sáinz M, Treceño C Vaccine 33 (3), 3773-8, 2015 | 125 | 2015 |
Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of … C Treceño, LH Martin Arias, M Sáinz, I Salado, P Garcia Ortega, ... Pharmacoepidemiology and drug safety 21 (4), 435-441, 2012 | 53 | 2012 |
Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption LH Martin Arias, CT Lobato, S Ortega, A Velasco, A Carvajal, JG del Pozo Pharmacoepidemiology and drug safety 19 (9), 895-900, 2010 | 34 | 2010 |
New anticoagulant agents: incidence of adverse drug reactions and new signals thereof C Treceño-Lobato, MI Jiménez-Serranía, R Martínez-García, ... Seminars in Thrombosis and Hemostasis 45 (02), 196-204, 2019 | 24 | 2019 |
Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study LHM Arias, C Treceno, P Garcia-Ortega, J Rodríguez-Paredes, ... European journal of clinical pharmacology 69, 559-564, 2013 | 20 | 2013 |
Emergency contraceptive pill safety profile. Comparison of the results of a follow‐up study to those coming from spontaneous reporting A Carvajal, M Sáinz, V Velasco, P García Ortega, C Treceño, ... Pharmacoepidemiology and drug safety 24 (1), 93-97, 2015 | 13 | 2015 |
Antipsychotics and cardiovascular risk: A case/non-case study LHM Arias, RS Fadrique, SP García, MS Gil, CT Lobato, PG Ortega Psychiatry Research 270, 341-347, 2018 | 9 | 2018 |
Risk excess of mortality and use of antipsychotics: a case–noncase study LHM Arias, CT Lobato, SP García, MS Gil, RS Fadrique, PG Ortega International Clinical Psychopharmacology 32 (1), 1-5, 2017 | 6 | 2017 |
Influence of concomitant treatments under anticoagulants and statins in detecting signals of adverse drug reactions MI Jimenez-Serrania, C Treceño-Lobato Seminars in Thrombosis and Hemostasis 45 (08), 837-845, 2019 | 5 | 2019 |
Knowledge upon the emergency contraceptive pill in Spain LG Sevillano, M Pellón, CT Lobato, MS Gil, IS Valdivieso European journal of clinical pharmacy: atención farmacéutica 16 (3), 224-228, 2014 | 3 | 2014 |
Experiences from the Sentinel Surveillance Network of Pharmacies in Castilla y León CT Lobato FarmaJournal 4 (1), 96-96, 2019 | 2 | 2019 |
Impact of regulatory measures on antipsychotics drug consumption in Castilla y Leon, Spain LHM Arias, CT Lobato, SP García, PG Ortega, MS Gil, RS Fadrique, ... Public health 141, 113-119, 2016 | 2 | 2016 |
Valoración de la incidencia de PRM/RNM en pacientes tratados con anticoagulantes orales y evaluación de la intervención farmacéutica en farmacia comunitaria CT Lobato, EV Martín FarmaJournal 8 (1), 33-47, 2023 | | 2023 |
Evaluación de la intervención en paciente diabético en la farmacia comunitaria (zona urbana en Valladolid durante el periodo de abril a junio del 2021) E Valles Martín, E Mateos Rodríguez, C Treceño Lobato, ... Ediciones Universidad de Salamanca (España), 2022 | | 2022 |
Trabajo coordinado y en red desde la Red de Farmacias Centinela: Re-solución de problemas de morbilidad prevenible CT Lobato Pharmaceutical Care España 24 (Supp 1), 47-48, 2022 | | 2022 |
Es hora de pasar de la estrategia a la acción CT Lobato Pharmaceutical Care España 23 (3), 201-202, 2021 | | 2021 |
Atypical Fracture of the Sternum After Long-Term Alendronate Plus Cholecalciferol Treatment: A Case Report LH Martín Arias, P García Ortega, M Sáinz Gil, E Navarro García, ... Drug Safety-Case Reports 4 (1), 5, 2017 | | 2017 |
Atypical Fracture of the Sternum After Long-Term Alendronate Plus Cholecalciferol Treatment: A Case Report LHM Arias, PG Ortega, MS Gil, EN García, CT Lobato, VD Armas Drug safety-case reports 4 (1), 5, 2017 | | 2017 |
X Congreso Nacional de Atención Farmacéutica AD Martinez, CT Lobato Pharmaceutical Care España 19 (5), 235-236, 2017 | | 2017 |
X-th National Congress of Pharmaceutical Care A Dago Martinez, C Treceno Lobato PHARMACEUTICAL CARE ESPANA 19 (5), 235-236, 2017 | | 2017 |